02: No Security without Research: On the Patients Right to Medical Advances
-
Liechtenstein-Saal
Breakout
/
German and English languageIn the community of solidarity in which we live in the West, certainty and security are the mainstays of a modern health policy. But what if economic constraints were such that the certainty that each patient is entitled to the best medical care available was no longer a given? Do patients have a right to medical progress? Or has such progress now become a luxury? Moreover, what can and must politics do to ensure that research into and the development of modern pharmaceuticals do not come to a standstill? The working party of the Forum of Research-Based Pharmaceutical Industry (FOPI) attempts to find answers to these major issues.
| |||||
| |||||
| |||||
| |||||
|
Franz BITTNER
Geschäftsführer, Peri Human Relations GmbH, Wien
| 1986-1987 | Sozialakademie |
| 1993-2006 | Vorsitzender der Gewerkschaft Druck-Journalismus-Papier |
| 1997-2009 | Obmann der Wiener Gebietskrankenkasse |
| seit 2006 | Stv. Vorsitzender Gewerkschaft der Privatangestellten, Druck-Journalismus-Papier (GPA/DJP) |
Rodney ELGIE
Vice President, European Men's Health Forum, London
| Qualified as a lawyer in 1969 specialising in commercial law and remained in private practice until 1991, rising to the position of senior partner of the practice in 1984. Suffered from clinical depression and joined Depression Alliance in the UK in 1992 and the Defeat Depression Campaign of the Royal College of Psychiatrists. Became the first Executive Director of Depression Alliance in April, 1994, and oversaw the growth of the registered charity from two staff and twelve volunteers with an annual income of £30,000 to one in 1999 of twenty staff, over two hundred volunteers and an annual income in excess of £750,000. Left Depression Alliance in 1999 to head the Global Alliance of Mental Illness Advocacy Networks-Europe (GAMIAN-Europe) with specific responsibilities for raising the profile of mental health at a pan-European level through the European Parliament and the Commission and the implementation of training programmes for new mental illness advocacy groups operating in Southern and Eastern Europe. Currently, the Immediate Past President and a Board Member of GAMIAN-Europe and on its Executive Committee. |
Dr. Andreas PENK
Regional President, Oncology International Developed Markets, Pfizer, Berlin
| 2002 | Country Manager Austria, Pfizer, Berlin |
| 2007 | Country Manager Germany, Pfizer, Berlin |
| 2008 | President Oncology Western Europe , Pfizer, Berlin |
| since 2014 | President Oncology Europe, Africa, Middle East, Pfizer, Berlin |
| since 2015 | Head, Greater China and Asia Pacific Regions Pfizer, Berlin |
Dr. Evelyn WALTER
Geschäftsführerin, IPF Institut für Pharmaökonomische Forschung, Wien
| Promotion in Volkswirtschaft | |
| 1998-1999 | Freie Projektmitarbeiterin am Industriewissenschaftlichen Institut |
| 2000-2003 | Wissenschaftliche Mitarbeiterin am Industriewissenschaftlichen Institut |
| 2003-2004 | Lektorin an der Wirtschaftsuniversität Wien |
| seit 2003 | Geschäftsführerin des Instituts für Pharmaökonomische Forschung |
Mag. Claudia DANNHAUSER
Moderator, ORF - Austrian Broadcasting Corporation, Vienna
| since 2011 | Editor for Domestic Policy for the Austrian newspaper "Die Presse", specialised in Health Policy |
| Journalist, ORF-Austrian Broadcasting Corporation, Zeit im Bild, Domestic Policy and European Union |
